Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan
· Delayed Price · Currency is TWD 60.10
-2.50 (-3.99%)
At close: Mar 9, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.08 billion as of March 9, 2026. Its market cap has increased by 3.23% in one year.
Market Cap
3.08B
Enterprise Value
2.68B
Revenue
159.02M
Ranking
n/a
PE Ratio
146.61
Stock Price
60.10
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.08B, an increase of 121.06%. That is a compound annual growth rate of 63.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.08B | -14.14% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.19B |
| SYN-TECH Chem. & Pharm. | 3.19B |
| SunWay Biotech Co., LTD. | 3.18B |
| Superior Plating Technology | 3.18B |
| GrandTech Cloud Services | 3.24B |
| ShareHope Medicine | 3.17B |
| Asia Electronic Material | 3.25B |
| ICARES Medicus | 3.25B |